|
|
|
|
In Vitro & In Vivo Diagnostic Substances Industry
Cash-Flow Margins, Effective Tax Rates Information & Trends
Effective Tax Rate
Statistics |
| |
| Effective Tax Rate Comment |
In Vitro & In Vivo Diagnostic Substances Industry's effective tax rate in 1 Q increased compare to previous quarter to 38.5 %, above Industry average.
Within Healthcare sector 4 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 54.
|
| Effective Tax Rate Statistics |
| High |
Average |
Low |
| 235.84 % |
-636.64 % |
-10539.51 % |
| 2. quarter 2022 |
|
4. quarter 2021 |
| Effective Tax Rate Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 54
|
Effective Tax Rate
Statistics |
|
|
| Effective Tax Rate Comment |
In Vitro & In Vivo Diagnostic Substances Industry's effective tax rate in 1 Q increased compare to previous quarter to 38.5 %, above Industry average.
Within Healthcare sector 4 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 54.
|
| Effective Tax Rate Statistics |
| High |
Average |
Low |
| 235.84 % |
-636.64 % |
-10539.51 % |
| 2. quarter 2022 |
|
4. quarter 2021 |
|
| Effective Tax Rate Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 54
|
|
Industry: In Vitro & In Vivo Diagnostic Substances ▼
|
Category:
|
|
| In Vitro & In Vivo Diagnostic Substances Industry |
1 Q |
4 Q |
3 Q |
2 Q |
1 Q |
|
|
2025 |
2024 |
2024 |
2024 |
2024 |
| Free Cash Flow Margin |
7.82 % |
19.17 % |
16.63 % |
7.95 % |
9.04 % |
| Free Cash Flow Margin (TTM) |
16.82 % |
19.9 % |
19.05 % |
19 % |
17.78 % |
| Free Cash Flow Margin Ranking |
# 28 |
# 30 |
# 20 |
# 62 |
# 15 |
| Net Cash Flow Margin |
- |
0 % |
- |
- |
- |
| Net Cash Flow Margin (TTM) |
- |
- |
1.73 % |
5.81 % |
4.04 % |
| Net
Cash Flow Margin Ranking |
# 28 |
# 30 |
# 20 |
# 62 |
# 15 |
| Effective Tax Rate |
38.5 % |
- |
30.02 % |
58.18 % |
- |
| Effective Tax Rate (TTM) |
- |
- |
- |
- |
- |
| Effective Tax Rate Ranking |
# 54 |
# 31 |
# 27 |
# 3 |
# 38 |
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
Free Cash Flow Margin Comment |
In Vitro & In Vivo Diagnostic Substances Industry experienced contraction in Free Cash Flow by -50.74 % and Revenue by -0.53 %, while Free Cash Flow Margin fell to 7.82 %, higher than Industry's average Free Cash Flow Margin.
On the trailing twelve months basis Free Cash Flow Margin in 1 Q fell to 16.82 %.
Within Healthcare sector 2 other industries have achieved higher Free Cash Flow Margin. Free Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 28.
|
| Free Cash Flow Margin Statistics |
| High |
Average |
Low |
| 94.99 % |
-428.9 % |
-5419.13 % |
| 4. quarter 2020 |
|
4. quarter 2021 |
| Free Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 3 |
| Overall |
# 28
|
Net Cash Flow Margin Statistics |
|
|
| Net
Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 3 |
| Overall |
# 41
|
| Net Cash Flow Margin Statistics |
| High |
Average |
Low |
| 104.6 % |
-307.21 % |
-5849.98 % |
| 4. quarter 2020 |
|
4. quarter 2021 |
| Net
Cash Flow Margin Comment |
In Vitro & In Vivo Diagnostic Substances Industry recorded net cash spending compare to Net Cash Flow achieved in previous quarter.
Within Healthcare sector 2 other industries have achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 41.
|
Net Cash Flow Margin Statistics |
|
|
| Net
Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 3 |
| Overall |
# 41
|
|
| Net Cash Flow Margin Statistics |
| High |
Average |
Low |
| 104.6 % |
-307.21 % |
-5849.98 % |
| 4. quarter 2020 |
|
4. quarter 2021 |
| Net
Cash Flow Margin Comment |
In Vitro & In Vivo Diagnostic Substances Industry recorded net cash spending compare to Net Cash Flow achieved in previous quarter.
Within Healthcare sector 2 other industries have achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 41.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
